David James Pinato

81PUBLICATIONS

561CO-AUTHORS

Solid tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Innate immunityPredictive and prognostic markers

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (81)

Sort by Publication Date:

|Jun 04, 2026

A first-in-human, open-label multicentre Phase 1 study of the orally administered E7386 in patients with selected advanced neoplasms.

|May 13, 2026

Early ctDNA Dynamics Predict Response to Mosperafenib in BRAF V600-Mutant Metastatic Colorectal Cancer.

|Mar 27, 2026

Phase I Study of Mosperafenib, a Novel Paradox Breaker B-Raf Proto-Oncogene Serine/Threonine Kinase (BRAF) Inhibitor, in Patients With <i>BRAF</i> V600-Mutant Solid Tumors.

Maria Vieito, Elisa Fontana, Catherine H Han

|Feb 12, 2026

Antibiotic Use Linked to Worse Outcomes in Patients With Gastrointestinal and Liver Cancer on Immune Checkpoint Inhibitors: A Meta-Analysis.

Mohammad Saeid Rezaee-Zavareh, Hamidreza Karimi-Sari, Peyvand Parhizkar Roudsari

|Feb 12, 2026

Integration of local and systemic immunotherapy: setting new standards in liver-confined hepatocellular carcinoma.

Pei-Chang Lee, Yi-Hsiang Huang, David James Pinato

|Oct 06, 2025

Preliminary qualification of a machine learning-based assessment of the tumor immune infiltrate as a predictor of outcome in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab.

Bernhard Scheiner, Pasquale Lombardi, Antonio D'Alessio

Pageof 14

Frequent Collaborators

23 joint publications

Alessio Cortellini

13 joint publications

Antonio D'Alessio

Lorenza Rimassa

Matthias Pinter

Yi-Hsiang Huang

Masatoshi Kudo

Giuseppe Cabibbo

Lorenz Balcar

Claudia Angela Maria Fulgenzi

4 joint publications

Bernhard Scheiner

Frequent Collaborators

23 joint publications

Alessio Cortellini

13 joint publications

Antonio D'Alessio

7 joint publications

Lorenza Rimassa

6 joint publications

Matthias Pinter